Dialectic Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

Dialectic Therapeutics General Information

Description

Operator of a biotechnology company intended to create new technologies to treat cancer. The company's drugs specialize in inducing cancer cells to degrade B-cell lymphoma, stimulating the cells to commit suicide or become susceptible to chemotherapy, enabling patients to have increased disease-free survival.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12200 North Stemmons Freeway
  • Suite 100
  • Dallas, TX 75234
  • United States
+1 (972)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 12200 North Stemmons Freeway
  • Suite 100
  • Dallas, TX 75234
  • United States
+1 (972)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dialectic Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Mar-2023 Completed Clinical Trials - Phase 1
6. Grant 20-Aug-2021 Completed Clinical Trials - Phase 1
5. Seed Round 11-Feb-2021 Completed Clinical Trials - Phase 1
4. Angel (individual) 06-Oct-2020 Completed Startup
3. Grant 26-Feb-2020 Completed Startup
2. Seed Round 13-Nov-2018 $2M $2M Completed Startup
1. Spin-Off 01-Jan-2018 Completed Startup
To view Dialectic Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Dialectic Therapeutics Patents

Dialectic Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026050093-A1 Combination therapies for the treatment of advanced malignancies including solid tumors Pending 27-Aug-2024
AU-2021377235-A1 Small molecule formulation Pending 10-Nov-2020
AU-2021377235-A9 Small molecule formulation Pending 10-Nov-2020
CA-3196536-A1 Small molecule formulation Pending 10-Nov-2020
EP-4243775-A1 Small molecule formulation Pending 10-Nov-2020 A61K9/107
To view Dialectic Therapeutics’s complete patent history, request access »

Dialectic Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dialectic Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altamont Pharmaceutical Holdings Holding Company Minority
Cancer Prevention and Research Institute of Texas Government
University of Florida University
To view Dialectic Therapeutics’s complete investors history, request access »

Dialectic Therapeutics FAQs

  • When was Dialectic Therapeutics founded?

    Dialectic Therapeutics was founded in 2018.

  • Where is Dialectic Therapeutics headquartered?

    Dialectic Therapeutics is headquartered in Dallas, TX.

  • What is the size of Dialectic Therapeutics?

    Dialectic Therapeutics has 5 total employees.

  • What industry is Dialectic Therapeutics in?

    Dialectic Therapeutics’s primary industry is Drug Discovery.

  • Is Dialectic Therapeutics a private or public company?

    Dialectic Therapeutics is a Private company.

  • What is Dialectic Therapeutics’s current revenue?

    The current revenue for Dialectic Therapeutics is .

  • How much funding has Dialectic Therapeutics raised over time?

    Dialectic Therapeutics has raised $8.85M.

  • Who are Dialectic Therapeutics’s investors?

    Altamont Pharmaceutical Holdings, Cancer Prevention and Research Institute of Texas, and University of Florida have invested in Dialectic Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process